2024
The potential of non-psychedelic 5-HT2A agents in the treatment of substance use disorders: a narrative review of the clinical literature
Pulido-Saavedra A, Borelli A, Kitaneh R, Alrafayia M, Jalilian-Khave L, Funaro M, Potenza M, Angarita G. The potential of non-psychedelic 5-HT2A agents in the treatment of substance use disorders: a narrative review of the clinical literature. Expert Opinion On Pharmacotherapy 2024, 26: 133-146. PMID: 39708346, PMCID: PMC11786980, DOI: 10.1080/14656566.2024.2446623.Peer-Reviewed Original ResearchConceptsTreatment of substance use disordersSubstance use disordersTreating substance use disordersPsychedelic agentsNarrative reviewReceptor agonistsClinical literatureReceptor antagonistNovel interventionsClinical evidenceFDA approvalPublic health issueDisordersReceptorsAgonistsTreatmentCravingPositive resultsPsychedelicsAbstinenceReviewed literatureAgentsHealth issuesAntagonistPrimary affinityConsistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression
Høgsted E, Beliveau V, Ozenne B, Madsen M, Svarer C, Dam V, Johansen A, Fisher P, Knudsen G, Frokjaer V, Sankar A. Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression. The British Journal Of Psychiatry 2024, 226: 137-143. PMID: 39632615, DOI: 10.1192/bjp.2024.143.Peer-Reviewed Original ResearchFacets of neuroticismCortisol awakening responseHPA axis functionR bindingReduce neuroticismAxis functionPositron emission tomographyNEO Personality InventoryNEO-PI-RAssessment of neuroticismSerotonin 2A receptorMarkers of depressionTreatment of depressionPersonality InventoryMood symptomsAwakening responseNeuroticismPositive associationLatent variable modelsSelf-ConsciousnessDepressionReceptor bindingNovel interventionsPsilocybinFindings prompt considerationIntroduction: Why This? Why Now?
Gearhardt A, Brownell K, Gold M, Potenza M. Introduction: Why This? Why Now? 2024, xxiii-xxvi. DOI: 10.1093/oso/9780190671051.002.0006.Peer-Reviewed Original ResearchResearch Review: Why do prospective and retrospective measures of maltreatment differ? A narrative review
Coleman O, Baldwin J, Dalgleish T, Rose‐Clarke K, Widom C, Danese A. Research Review: Why do prospective and retrospective measures of maltreatment differ? A narrative review. Journal Of Child Psychology And Psychiatry 2024, 65: 1662-1677. PMID: 39150090, PMCID: PMC11834142, DOI: 10.1111/jcpp.14048.Peer-Reviewed Original ResearchMeasures of maltreatmentChildhood maltreatmentRetrospective measuresMeasures of childhood maltreatmentMental health burdenReports of maltreatmentRetrospective reportsMaltreatmentAssess maltreatmentPsychopathologyGroup of individualsNovel interventionsMethodological issuesHealth burdenData collection methodsMotivating individualsMeasure disagreementIndividualsMulti-disciplinary researchMemoryCollection methodsThe sinking platform test: a novel paradigm to measure persistence in animal models
Floris G, Godar S, Braccagni G, Piras I, Ravens A, Zanda M, Huentelman M, Bortolato M. The sinking platform test: a novel paradigm to measure persistence in animal models. Neuropsychopharmacology 2024, 49: 1373-1382. PMID: 38396257, PMCID: PMC11251282, DOI: 10.1038/s41386-024-01827-0.Peer-Reviewed Original ResearchConceptsChronic administration of fluoxetinePrefrontal cortex of miceWeeks of social isolationAdministration of fluoxetineMeasure persistenceGoal-directed actionsSocially isolated miceMitigate depression riskCortex of micePlatform testVoluntary wheel runningChronic haloperidolPrefrontal cortexTemperamental traitsImipramine treatmentNeurobiological foundationsBehavioral tasksChronic stressChronic administrationImmediate-early genesFailure TrialWheel runningDepression riskAnimal modelsNovel interventionsThe role of neurosteroids in posttraumatic stress disorder and alcohol use disorder: A review of 10 years of clinical literature and treatment implications
Peltier M, Verplaetse T, Altemus M, Zakiniaeiz Y, Ralevski E, Mineur Y, Gueorguieva R, Picciotto M, Cosgrove K, Petrakis I, McKee S. The role of neurosteroids in posttraumatic stress disorder and alcohol use disorder: A review of 10 years of clinical literature and treatment implications. Frontiers In Neuroendocrinology 2024, 73: 101119. PMID: 38184208, PMCID: PMC11185997, DOI: 10.1016/j.yfrne.2023.101119.Peer-Reviewed Original ResearchPosttraumatic stress disorderAlcohol use disorderStress disorderContext of PTSDPTSD/AUDConcurrent posttraumatic stress disorderUnderlying neurobiological mechanismsUse disordersAlcohol-related variablesNeurobiological mechanismsPTSD diagnosisTreatment developmentTreatment implicationsBody of literatureNovel interventionsClinical literatureRole of neurosteroidsDisordersTreatment outcomesYears of researchAlcohol consumptionExogenous pregnenolonePharmacological treatmentBiological variablesAllopregnanolone
2023
Emergency department care transitions for persons living with cognitive impairment and care partners: development of a novel artificial intelligence and care coach intervention
Galske J, Gil H, Dorai C, Keefe K, Stern E, DeFrancesco E, Gettel C. Emergency department care transitions for persons living with cognitive impairment and care partners: development of a novel artificial intelligence and care coach intervention. Alzheimer's & Dementia 2023, 19 DOI: 10.1002/alz.075447.Peer-Reviewed Original ResearchCare transitionsCare partnersCoach interventionCognitive impairmentEmergency Department Care TransitionsIntegration of findingsED discharge processEmergency department presentationsSemi-structured focus groupsHealth care professionalsArtificial intelligenceSubsequent EDFocus groupsED settingOutpatient settingEffective interventionsCare continuumNovel interventionsCare professionalsSentinel eventsED experienceIntervention adoptionUnique needsEmpathy mapUser-centered design approachSurrogacy and the Valuation of ATMPs: Taking Our Place in the Evidence Generation/Assessment Continuum
Gladwell D, Ciani O, Parnaby A, Palmer S. Surrogacy and the Valuation of ATMPs: Taking Our Place in the Evidence Generation/Assessment Continuum. PharmacoEconomics 2023, 42: 137-144. PMID: 37991631, DOI: 10.1007/s40273-023-01334-y.Peer-Reviewed Original ResearchAdvanced therapy medicinal productsTherapy medicinal productsSurrogate primary endpointTrial-level correlationSingle-arm studyMedicinal productsMechanism of actionHealth technology assessmentPrimary endpointPatient relevanceNovel interventionsAdvanced therapiesTreatment effectsEndpointTechnology assessmentSurrogacy relationshipsSurrogate relationshipsMedical technologyTherapyAdditional avenuesLaboratory and Real-World Experimental Approaches to Understanding Alcohol Relapse
Milivojevic V, Sinha R. Laboratory and Real-World Experimental Approaches to Understanding Alcohol Relapse. Current Topics In Behavioral Neurosciences 2023, 1-25. PMID: 37985542, DOI: 10.1007/7854_2023_456.Peer-Reviewed Original ResearchAlcohol use disorderUse disordersHuman laboratory proceduresHuman laboratory modelRelapse riskAlcohol cuesBiobehavioral markersPsychobiological mechanismsStress dysregulationChronic alcohol useAlcohol relapseAlcohol useEffective interventionsNovel interventionsStress biologyReal worldDisordersInterventionCuesSignificant implicationsSignificant treatment challengeHigher relapse riskAUDRisk factorsAdaptationPatient Values, Information Preferences, and Decisional Preferences Among Older Adults with Acute Myeloid Leukemia
Loh K, Mortaz-Hedjri S, Wang Y, Locastro M, Norton S, Mendler J, Liesveld J, Huselton E, Jensen-Battaglia M, Buettner K, Davis J, Klepin H, Richardson D. Patient Values, Information Preferences, and Decisional Preferences Among Older Adults with Acute Myeloid Leukemia. Blood 2023, 142: 2352. DOI: 10.1182/blood-2023-172827.Peer-Reviewed Original ResearchBest-worst scaling instrumentDecisional preferencesPatient valuesBest-worst scalingOlder adultsAssess demographicsInformation preferencesValues of older adultsAcute myeloid leukemiaGeneralized linear regression modelsQuality of lifeRandomized Controlled TrialsDiagnosed AMLYounger patientsLinear regression modelsMedical careAging-related conditionsCaregiversMedical decisionsNovel interventionsDaily activitiesCareDoctorsMultivariate analysisClinical outcomesPiloting an Innovative System-Level Intervention for Pediatric Patients with Inflammatory Bowel Disease and Social Risk
Wagner D, Stoeckel M, Hansen T, Muir L, Harris M. Piloting an Innovative System-Level Intervention for Pediatric Patients with Inflammatory Bowel Disease and Social Risk. Clinical Practice In Pediatric Psychology 2023, 11: 134-146. DOI: 10.1037/cpp0000481.Peer-Reviewed Original ResearchHigh social riskRecommended preventive careAcute care useSystem-level interventionsHealthcare utilization dataFrequency of hospital admissionsInflammatory bowel diseasePretest-posttest designCare useImprove disease managementPreventive careEHR recordsED visitsSocial risksUtilization dataHospital admissionNovel interventionsDemographic informationDisease managementService initiativesAttendance dataChildren's HealthcareIncreased engagementBowel diseaseChart reviewAdaptation of Nontypeable Haemophilus influenzae in Human Airways in COPD: Genome Rearrangements and Modulation of Expression of HMW1 and HMW2
Murphy T, Kirkham C, D’Mello A, Sethi S, Pettigrew M, Tettelin H. Adaptation of Nontypeable Haemophilus influenzae in Human Airways in COPD: Genome Rearrangements and Modulation of Expression of HMW1 and HMW2. MBio 2023, 14: e00140-23. PMID: 36927061, PMCID: PMC10127715, DOI: 10.1128/mbio.00140-23.Peer-Reviewed Original ResearchConceptsChronic obstructive pulmonary diseaseNontypeable Haemophilus influenzaeObstructive pulmonary diseaseRespiratory epithelial cellsHuman airwaysHaemophilus influenzaeAirway inflammationLung functionMechanisms of persistencePulmonary diseaseEpithelial cellsNovel interventionsChronic lower airway infectionsProgressive lossAirways of adultsLower airway infectionHuman respiratory epithelial cellsCommon debilitating disorderStrains of NTHiNTHi infectionAirway infectionLower airwaysCommon causeSequential isolatesSerial isolatesPerceived stigma related to TB preventive therapy
Palacios C, Hough M, Shrestha R, Moll A, Kompala T, Andrews L, Shenoi S. Perceived stigma related to TB preventive therapy. The International Journal Of Tuberculosis And Lung Disease 2023, 27: 209-214. PMID: 36855038, DOI: 10.5588/ijtld.22.0570.Peer-Reviewed Original ResearchConceptsTB preventative therapyTB preventive therapyAnonymous cross-sectional surveyBurden of TBCommunity-dwelling adultsRural South African communityCross-sectional surveyPreventive therapyMean agePreventative therapyEndemic settingsPatient's familyKruskal-Wallis testStigma scoresRural South AfricaPoisson regressionNovel interventionsSouth African communityTherapyLess stigmaDescriptive statisticsFamily membersStigmaTBTwo-factor solution
2022
PET Imaging of Synaptic Density: Challenges and Opportunities of Synaptic Vesicle Glycoprotein 2A PET in Small Animal Imaging
Toyonaga T, Fesharaki-Zadeh A, Strittmatter SM, Carson RE, Cai Z. PET Imaging of Synaptic Density: Challenges and Opportunities of Synaptic Vesicle Glycoprotein 2A PET in Small Animal Imaging. Frontiers In Neuroscience 2022, 16: 787404. PMID: 35345546, PMCID: PMC8957200, DOI: 10.3389/fnins.2022.787404.Peer-Reviewed Original ResearchAnimal modelsPET imaging studiesPET imagingImaging studiesSynaptic vesicle glycoprotein 2ADisease animal modelsOngoing clinical investigationsDifferent injection routesSynaptic densityClinical investigationPharmacological effectsRodent brainNovel interventionsInjection routeNeurodegenerative disordersNeuropsychiatric diseasesPET studiesBrainMultiple diseasesPET centersDiseaseInjectable volumeImagingSmaller brainsPETIntrinsic Connectivity and Family Dynamics: Striatolimbic Markers of Risk and Resilience in Youth at Familial Risk for Mood Disorders
Fischer AS, Holt-Gosselin B, Hagan KE, Fleming SL, Nimarko AF, Gotlib IH, Singh MK. Intrinsic Connectivity and Family Dynamics: Striatolimbic Markers of Risk and Resilience in Youth at Familial Risk for Mood Disorders. Biological Psychiatry Cognitive Neuroscience And Neuroimaging 2022, 7: 855-866. PMID: 35272095, PMCID: PMC9452604, DOI: 10.1016/j.bpsc.2022.02.009.Peer-Reviewed Original ResearchConceptsLow-risk youthMood disordersFunctional connectivityFamilial riskFC differencesFC relativeRisk statusMajor depressive disorderHigh familial riskDepressive disorderMore effective interventionsBipolar disorderNovel interventionsIntrinsic connectivityEffective interventionsFrontal gyrusDisordersRiskGyrusPsychopathologyFamily rigidityNeural underpinningsInterventionNeural signaturesFamily dynamicsMeasuring Voluntary Control Over Hallucinations: The Yale Control Over Perceptual Experiences (COPE) Scales
Mourgues C, Hammer A, Fisher V, Kafadar E, Quagan B, Bien C, Jaeger H, Thomas R, Sibarium E, Negreira AM, Sarisik E, Polisetty V, Eken H, Imtiaz A, Niles H, Sheldon AD, Powers AR. Measuring Voluntary Control Over Hallucinations: The Yale Control Over Perceptual Experiences (COPE) Scales. Schizophrenia Bulletin 2022, 48: 673-683. PMID: 35089361, PMCID: PMC9077437, DOI: 10.1093/schbul/sbab144.Peer-Reviewed Original ResearchConceptsAuditory verbal hallucinationsPositive clinical outcomesClinical outcomesPilot studyQuality of lifeConvergent validityFrequent auditory verbal hallucinationsExperiences ScaleClinical measuresConventional treatmentNovel interventionsSymptom severitySignificant distressClinical scalesComprehensive batteryPsychosis-spectrum diagnosisVerbal hallucinationsSound psychometric propertiesAVH contentVoluntary controlPsychometric propertiesHallucinationsControl ScaleValidation studyIntervention
2020
Feasibility and acceptability of a pilot, peer-led HIV self-testing intervention in a hyperendemic fishing community in rural Uganda
Matovu JKB, Bogart LM, Nakabugo J, Kagaayi J, Serwadda D, Wanyenze RK, Ko AI, Kurth AE. Feasibility and acceptability of a pilot, peer-led HIV self-testing intervention in a hyperendemic fishing community in rural Uganda. PLOS ONE 2020, 15: e0236141. PMID: 32764751, PMCID: PMC7413506, DOI: 10.1371/journal.pone.0236141.Peer-Reviewed Original ResearchConceptsHIV-positiveHIVST kitsAdult menHIV self-testing interventionLow HIV testing ratesConfirmatory HIV testingHIV testing ratesHIV-positive individualsSocial network membersHIV diagnosisHIV testingHIV servicesHIV prevalenceHIVST interventionTesting ratesNovel interventionsHIVFeasibility benchmarksRural UgandaAcceptability benchmarkYoung peopleInterventionAdult malesKitMenGenetic Variation and Response to Neurocritical Illness: a Powerful Approach to Identify Novel Pathophysiological Mechanisms and Therapeutic Targets
Acosta JN, Brown SC, Falcone GJ. Genetic Variation and Response to Neurocritical Illness: a Powerful Approach to Identify Novel Pathophysiological Mechanisms and Therapeutic Targets. Neurotherapeutics 2020, 17: 581-592. PMID: 31975153, PMCID: PMC7283396, DOI: 10.1007/s13311-020-00837-2.Peer-Reviewed Original ResearchConceptsIll neurological patientsNovel pathophysiological mechanismsFinal FDA approvalNeurocritical illnessPathophysiological mechanismsTherapeutic optionsNeurocritical care researchTherapeutic targetNeurological patientsNew treatmentsFDA approvalNovel interventionsCare researchNew preventiveRehabilitation strategiesBiological pathwaysPatientsIllnessSummary and Future Applications of Precision Medicine in Pulmonary, Critical Care, and Sleep Medicine
Gomez J, Kaminski N, Himes B. Summary and Future Applications of Precision Medicine in Pulmonary, Critical Care, and Sleep Medicine. Respiratory Medicine 2020, 417-428. DOI: 10.1007/978-3-030-31507-8_28.Peer-Reviewed Original ResearchCritical careSleep medicinePrecision medicine strategiesNovel biomarker candidatesDisease endotypesClinical studiesDisease pathogenesisHealthcare providersNovel interventionsBiomarker candidatesMedicine strategiesPrecision medicineDrug targetsCareMolecular underpinningsWidespread implementationMedicineEndotypesPulmonaryPathogenesisCohortInitial discoveryBiomarkers
2019
Nicotine Use Disorders in Adolescents
Cavallo DA, Krishnan-Sarin S. Nicotine Use Disorders in Adolescents. Pediatric Clinics Of North America 2019, 66: 1053-1062. PMID: 31679596, DOI: 10.1016/j.pcl.2019.08.002.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply